Find Academic Supervisors

Daniel FinleyView profile

Professor

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +7 more

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

• Natural Products Research
• Phytomedicine
• Herbal Product Standardization
• +7 more

Roles & Affiliations: Ikhlas Khan serves as Director of the National Center for Natural Products Research (NCNPR), Distinguished Professor, and Research Professor of Pharmacognosy at the University of Mississippi's School of Pharmacy. He also leads the FDA Program and coordinates natural products research across multiple initiatives, including the Sino-US TCM Research Center and the Center for Research of Indian Systems of Medicine (CRISM). Education: B.Sc. Chemistry (1980) - Aligarh Muslim University, India M.Sc. Organic Chemistry (1982) - Aligarh Muslim University, India Ph.D. Pharmacy (1987) - Ludwig-Maximilians-Universität, Munich Postdoctoral Studies - Swiss Federal Institute of Technology (ETH), Zurich Research Focus: Dr. Khan specializes in natural products research with emphasis on: Phytomedicine: Standardization of herbal products via analytical fingerprinting, pesticide/herbicide residue analysis, and bioanalytical quality control. Drug Discovery: Isolation of bioactive natural products, development of analytical methods for phytochemical characterization, and chiral separation techniques. Metabolism Studies: Role of metabolism in drug/natural product activity, particularly in aminoquinoline antimalarials. His work bridges academia, industry, and regulatory bodies, shaping policies for botanical supplements. Key Contributions: Over 850 peer-reviewed publications and leadership in high-impact projects like the FDA Center of Excellence. His lab pioneered methods to combat herbal product adulteration and safety issues. Awards & Recognition: UM Distinguished Professor Award (2018) Wiley Award (AOAC International, 2018) Qihuang International Prize (2017) Honoris Causa Doctorate (University of Hamdard, 2012) Labs & Collaborations: Directs the NCNPR, a global leader in natural products research, and collaborates with institutions worldwide. His team develops technologies for herbal product authentication and drug metabolism studies.

Olga DontsovaView profile

Professor

• Molecular Biology
• Bioorganic Chemistry
• Ribonucleoprotein Complexes
• +3 more

Olga Dontsova is a Full Professor at Moscow State University (MSU) in the Faculty of Chemistry. She serves as Head of the Division of RNA Structure and Function at the Belozersky Institute of Physico-Chemical Biology and Head of the Chair of Chemistry of Natural Compounds. Her research spans molecular biology, bioorganic chemistry, and RNA-based mechanisms. Research Focus: She investigates structure-functional relationships in ribonucleoprotein complexes, with emphasis on translation machinery, transfer-messenger RNA (tmRNA) interactions with ribosomes, RNA methyltransferases, and telomerase's role in cancer. Her team pioneered a chemical-biochemical-genetic approach to map mRNA topography in ribosomes, elucidate trans-translation dynamics, and characterize novel RNA-modifying enzymes. Scientific Contributions: Developed a molecular dynamic model for trans-translation Discovered unique yeast telomerase with unconventional properties Investigated functional roles of modified RNA residues in translation Honors: Member of Academia Europaea (2014) Corresponding Member of Russian Academy of Sciences (2006) European Academy Award for Young Scientists (1994) Grants & Leadership: Her work has been funded by HHMI, HFSP, CRDF, INTAS, RFFI, and Russian Ministry of Science and Education. She chairs the Biology Panel of the Russian Scientific Foundation and serves on editorial boards for Biochimie, Russian Journal of Molecular Biology, and Acta Naturae. Teaching: As a supervisor of 21 Ph.D. students and numerous diploma projects, she teaches advanced courses at MSU while maintaining an active research program.

Connor ColeyView profile

Assistant Professor

• Machine Learning for Chemistry
• Computer-Aided Molecular Design
• Synthesis Planning
• +5 more

Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.

Paul StuppleView profile

Professor

• Small Molecule Drug Discovery
• Cancer Therapeutics
• Pharmaceutical Chemistry
• +3 more

Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.

Monica E. McCallumView profile

Assistant Professor

• Microbial Chemistry
• Natural Products Synthesis
• Biochemistry
• +3 more

Dr. Monica E. McCallum is an Assistant Professor of Chemistry in the Department of Chemistry at the University of Pennsylvania’s School of Arts & Sciences. Her research focuses on understanding the biochemical origins of natural products and their roles in microbial communication. She leads the McCallum Lab, which employs interdisciplinary approaches combining organic synthesis, biochemistry, microbiology, and microscopy to study microbial natural products in their native contexts. Education: 2016 – Postdoctoral Fellow at Harvard University under Prof. Emily P. Balskus 2016 – PhD in Organic Chemistry from Baylor University 2013 – PhD Candidate at Colorado State University 2011 – B.S. in Chemistry from University of California, Irvine Research Interests: Dr. McCallum’s work bridges organic synthesis and microbiology to decode microbial metabolite functions. Key themes include: Synthesizing complex natural products and their biosynthetic precursors Discovering novel enzyme-catalyzed reactions Unraveling microbial communication mechanisms via natural products Investigating environmental microbial community dynamics Lab & Collaborations: The McCallum Lab emphasizes interdisciplinary collaboration, integrating techniques from organic chemistry, molecular biology, and microscopy to study natural products in situ. Current projects focus on diazeniumdiolate biosynthesis pathways and enzymatic detoxification of marine toxins.

Chang-Jun LiuView profile

Adjunct Professor

• Phenylpropanoid biosynthesis
• Lignin biosynthesis and modification
• Plant cell wall structure
• +7 more

Chang-Jun Liu is a Senior Scientist in the Plant Science Group of the Biology Department at Brookhaven National Laboratory, where he has conducted research on plant phenylpropanoid biosynthesis and lignin metabolism since joining in 2005. He also holds an Adjunct Professor position in the Biochemistry & Cell Biology Department at Stony Brook University and serves as Associate Editor for Plant Cell & Environment (2024-present) and Frontiers in Plant Sciences (2015-present). Dr. Liu's educational background includes: Ph.D. in Plant Biochemistry and Molecular Biology from the Shanghai Institute of Plant Physiology, Chinese Academy of Science (1999) Dr. Liu's research integrates approaches from biochemistry, molecular genetics, biophysics, protein engineering, metabolic engineering, and synthetic biology to investigate phenylpropanoid and lignin biosynthesis in plants. His laboratory addresses fundamental questions about how lignin and related compounds are synthesized and incorporated into cell walls, how regulatory networks govern metabolic activity, and how lignification influences cell wall structure and function. A central aim of his research is optimizing plant feedstocks for efficient lignocellulosic biomass utilization. Analysis of Dr. Liu's publication record reveals a consistent trajectory from fundamental biochemical mechanisms to applied bioenergy solutions. His recent work focuses on cytochrome b5 diversity, electron transfer mechanisms in phenolic biosynthesis, and metabolic engineering approaches to modify lignin composition. This research spans from evolutionary studies of lignin biosynthesis across plant lineages to practical applications in bioenergy crop improvement. Dr. Liu has received recognition for his contributions to science, including: Brookhaven National Laboratory Science and Technology Award (2018) Dr. Liu serves as Editorial Board Member for the Journal of Biological Chemistry (2020-present), PNAS Nexus (2024-present), and Plant Physiology Journal (2025-). He is Scientific Lead at the Joint BioEnergy Institute, Feedstocks Division, Lawrence Berkeley National Laboratory, and Project Lead at the Center for Bioenergy Innovation, Oak Ridge National Laboratory. His research is funded by the U.S. Department of Energy through multiple Bioenergy Research Centers. Dr. Liu leads a research group at Brookhaven National Laboratory focused on elucidating the posttranslational regulation and macromolecular organization of lignin biosynthesis, with applications toward developing designer lignins and reducing biomass recalcitrance for sustainable biofuel production. His work addresses the critical challenge of lignin's dual nature: while it impedes enzymatic access to polysaccharides in biofuel production, it also represents the most abundant renewable source of aromatic carbon for high-value bioproducts.

Dewey G. McCaffertyView profile

Professor

• Chemical Biology
• Chromatin Modification
• Enzymology
• +3 more

Dewey G. McCafferty is Professor of Chemistry at Duke University with appointments in Biochemistry and the Duke Cancer Institute. His research focuses on chemical biology of chromatin-modifying enzymes and ubiquitin signaling pathways relevant to neurodegeneration and infection. Notable work includes discovering the lasso peptide antibiotic Arcumycin, characterizing the Nedd4 ubiquitin ligase in Parkinson's disease models, and developing chemoproteomic approaches for target identification. Key contributions include elucidation of the futalosine pathway in Chlamydia infections, mechanisms of CPAF protease in bacterial pathogenesis, and engineering of histone demethylase enzymes. McCafferty received the Eli Lilly Award in Biological Chemistry (2005) and directs NIH-funded projects on ubiquitin ligases in neurodegeneration.

Samir H. MushrifView profile

Professor

• Computational Catalysis
• Molecular Modeling
• Reaction Engineering
• +7 more

Dr. Samir H. Mushrif is a Professor in the Department of Chemical and Materials Engineering at the University of Alberta . Prior to this role, he served as faculty at the School of Chemical and Biomedical Engineering at Nanyang Technological University (NTU), Singapore . He holds a PhD in Chemical Engineering from McGill University and completed postdoctoral research at the University of Delaware, USA . Education : PhD (Chemical Engineering, McGill University), Postdoc (University of Delaware) His research focuses on computational catalysis , molecular modeling , and reaction engineering for biomass conversion and CO2 reduction . He develops novel catalysts, solvents, and reactor systems using integrated quantum mechanical and classical molecular simulations , synergized with experimental data to enable sustainable energy and chemical production . Recent publications highlight trends in condensed phase chemistry for biomass reactions, machine learning applications in solvent configuration prediction, and mechanistic studies of lignin-carbohydrate complex deconstruction. His work bridges methane activation on metal oxides, hydrodeoxygenation of bio-oil compounds, and polymerization pathways in lignin structures. Scientific Awards include: NSERC Doctoral and Post-doctoral Fellowships Discovery International Award 2017 (Australian Research Council) NANYANG EDUCATION AWARD 2016 (Singapore) SCBE Teaching Excellence Awards (Silver 2015, Gold 2016) Bharat Gaurav (Pride of India) Award 2014 Dr. Mushrif's NSERC Discovery Grant (2018), CFI John R. Evans Leaders Fund Grant (2022), and AcRF Tier-2 Grant (Singapore, 2015) have advanced his work. Current PhD and Master's students include José Carlos Velasco Calderón , Arul Mozhi Devan Padmanathan , and Sagar Bathla , among others. The CARES Lab (Catalysis Research for Sustainability) under his leadership combines ab initio molecular dynamics , machine learning potentials , and Density Functional Theory to design materials for renewable energy . Collaborations span institutions in France , Canada , India , and the UK .

Angelo PeccerilloView profile

Professor

• Igneous petrology
• Geochemistry
• Volcanology
• +2 more

Angelo Peccerillo is a distinguished Full Professor of Petrology at the University of Perugia, Italy, with an extensive academic career spanning multiple Italian universities. He previously served as Full Professor of Petrology at the Universities of Calabria (1993-1997) and Messina (1985-1993), and as Associate Professor of Volcanology (1982-1985) and Assistant Professor (1971-1982) at the University of Florence. He earned his Laurea Degree in Geology from the University of Florence in 1970 and has been a member of Academia Europaea since his election. Peccerillo's research focuses on the petrology and geochemistry of magmatic processes, with particular expertise in igneous petrology, geochemistry, volcanology, orogenic volcanism, and continental rift magmatism. His scholarly work has established him as a leading expert in understanding the complex relationships between mantle processes, crustal interactions, and volcanic activity in the Mediterranean region and beyond. His research methodology integrates petrological, geochemical, and geophysical approaches to develop comprehensive models of magmatic systems. Analysis of Peccerillo's recent publications reveals a consistent focus on magmatic processes across diverse geological settings. His work spans from detailed studies of specific volcanic systems like the Aeolian Islands and Ethiopian Rift to broader investigations of mantle structure and geodynamic processes in the Mediterranean region. A recurring theme is the integration of multiple analytical approaches to model magma plumbing systems, understand mantle composition, and elucidate the geodynamic evolution of volcanic regions, particularly examining the relationships between deep and shallow mantle processes. Antonio Feltrinelli Price 2006 for Earth Sciences, awarded by the National Academy of Lincei, Italy Professor Peccerillo has supervised numerous MSc and PhD students both at his home institution and abroad. His editorial leadership includes serving as Chief Editor of the "European Journal of Mineralogy" from 2006 to 2008 and membership on the editorial boards of several prestigious journals including "Lithos," "Journal of Volcanology and Geothermal Research," "Geological Society of Italy Bulletin," and "Open Mineralogy Journal." He has been actively involved in research evaluation, serving on national and international panels for organizations such as NSF, ESF, CNR, MIUR, and NATO. Peccerillo maintains strong international scientific connections through visiting positions at institutions like the Australian National University, University of Gottingen, and University of Paris XI at Orsay. His leadership extends to professional organizations, having served as President of the Italian Petrology Group and currently as a Member of Academia Europaea. His administrative experience includes serving as Department Head and Coordinator of PhD programs at the Universities of Messina, Cosenza, and Perugia.

• Theoretical Plasma Physics
• Magnetic Reconnection
• Plasma Turbulence
• +4 more

James F. Drake is a Distinguished University Professor in the Department of Physics at the University of Maryland, College Park, with affiliations at the Institute for Physical Science and Technology (IPST) and the Institute for Research in Electronics and Applied Physics (IREAP). He holds a B.S., M.S., and Ph.D. in Physics from UCLA (1975). His research focuses on theoretical plasma physics, particularly magnetic reconnection and plasma turbulence, with applications to space physics, solar flares, and magnetic fusion. Key contributions include elucidating the role of whistler waves in reconnection dynamics and advancing understanding of energy release mechanisms in plasmas. Dr. Drake’s awards include the American Physical Society Fellowship and the Humboldt Senior Scientist Research Award. He teaches advanced physics courses (e.g., Physics 604, 611, 761-762) and has pioneered computational models to study reconnection, turbulence, and particle acceleration. Recent work leverages Parker Solar Probe data to explore solar wind dynamics and reconnection in near-Sun environments. Education: UCLA (B.S., M.S., Ph.D. in Physics, 1975) Research Themes: Magnetic Reconnection, Plasma Turbulence, Space Plasma Dynamics Notable Achievements: Leader in reconnection theory; developer of kinetic simulation frameworks; contributor to NASA missions

• Proteasome Research
• Structural Biology
• Enzyme Mechanisms
• +2 more

Michael Groll serves as Professor and Chair of Biochemistry at the Technical University of Munich (TUM), where he leads structural biology and enzymology research with a focus on proteasome mechanisms and inhibitor development. His laboratory, located at the Ernst-Otto-Fischer-Str. 8 campus in Garching, maintains active collaborations in drug discovery for cancer and infectious diseases. His primary research domains include proteasome inhibition, enzyme catalysis, and natural product biosynthesis, employing X-ray crystallography, biochemical assays, and bioengineering to dissect molecular mechanisms. Recent work emphasizes AI-guided enzyme optimization, bacterial stress response targeting, and structural characterization of halogenation enzymes, reflecting interdisciplinary approaches bridging chemistry and biology. Analysis of his 2023-2025 publications reveals consistent innovation in proteasome-targeted therapeutics, with 15 high-impact papers featuring structural insights into enzyme-inhibitor complexes and biosynthetic pathways. Key trends include engineering megasynthetases for immunoproteasome inhibitors, optical control of protein degradation, and elucidating metal-dependent mechanisms in antibiotic biosynthesis. No scientific awards were documented in the provided source material. While specific grant details and student mentorship records were not disclosed, his extensive publication record indicates leadership in collaborative research projects involving structural biology and chemical biology methodologies. The Chair of Biochemistry under Prof. Groll operates as a hub for structural enzymology, housing facilities for protein crystallography, enzyme kinetics, and natural product characterization. His team actively contributes to TUM's research ecosystem through partnerships with pharmaceutical groups and international structural biology consortia.

Deniz TasdemirView profile

Professor

• Marine Natural Products Chemistry
• Marine Ecology
• Biodiscovery
• +2 more

Prof. Dr. Deniz Tasdemir is a Full Professor (W3) of Marine Natural Products Chemistry at GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel and serves as Director of the GEOMAR-Biotech center and Head of the Marine Natural Product Chemistry Research Unit. Her career spans institutions including the National University of Ireland Galway and UCL School of Pharmacy. PhD in Pharmacy, ETH Zurich (1997) Post-doctoral work, University of Utah (2001) Dr. Helmut Legerlotz Fellowship, University of Zurich (2002-2025) Her research focuses on marine chemical ecology , metabolomics , and bioprospecting for bioactive compounds from sponges, algae, and marine microbiomes. Recent work explores seagrass pathogen reduction, microbiome interactions, and aquafeed applications. Scientific awards include: Waters Award for Natural Products Innovation (2016) Egon Stahl Silver Medal (2005) Pierre Fabre Prize (2004) ETH Zurich Medal (1997) She leads collaborative projects on ocean sustainability and marine drug discovery, with editorial roles in Marine Drugs , Planta Medica , and Phytochemistry Letters .

Graham DobereinerView profile

Associate Professor

• Homogeneous Catalysis
• Organometallic Chemistry
• Synthetic Chemistry
• +2 more

Graham Dobereiner is an Associate Professor and Robert L. Smith Early Career Professor in the Department of Chemistry at Temple University's College of Science and Technology. He received his Ph.D. from Yale University (2011) and completed postdoctoral research at MIT (2012-2014) after earning his B.S. from Brandeis University (2007). His research group develops novel homogeneous transition metal catalysts for synthetic chemistry applications spanning fine chemicals manufacturing, petrochemical processing, and drug discovery. The work integrates organometallic chemistry principles, combining organic molecular diversity with inorganic compound reactivity. Research areas include catalytic isomerization, oxidative synthesis, ligand design, and mechanistic studies of transition metal complexes. Analysis of his recent publications demonstrates strong emphasis on reaction mechanism elucidation, catalyst design for stereoselective transformations (particularly Z-selective isomerizations), and development of novel catalytic systems for sustainable synthesis. His group employs computational and experimental approaches to advance synthetic methodology.

Scott HopkinsView profile

Professor

• Physical Chemistry
• Machine Learning
• Mass Spectrometry
• +2 more

Scott Hopkins is a Professor in the Department of Chemistry at the University of Waterloo, specializing in Physical Chemistry. His research integrates machine learning with experimental techniques to study ion mobility, mass spectrometry, and spectroscopic analysis. He directs the Hopkins Laboratory, focusing on computational predictions of chemical behaviors and molecular interactions. His work addresses fundamental questions in gas-phase chemistry, cluster formation, and analytical method development. Research interests span physical chemistry, computational modeling, and analytical instrumentation, with a strong emphasis on developing predictive tools for complex chemical systems. Recent investigations explore ion-solvent dynamics, fragmentation mechanisms, and machine-learning applications for spectral interpretation.